共 50 条
- [1] Risk-Adapted Postmastectomy Radiation Therapy for pT1-2N1M0 Breast Cancer: A Single Institution Study [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E29 - E29
- [2] The Role of Postmastectomy Radiation Therapy in Clinical T1-3N1M0 Breast Cancer Patients With Pathological Negative Lymph Nodes After Neoadjuvant Chemotherapy and Mastectomy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E44 - E44
- [3] The effect of postmastectomy radiation therapy on high-risk patients with T1-2N0 breast cancer [J]. BREAST, 2021, 60 : 1 - 5
- [4] Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cTI-2N0-I after neoadjuvant chemotherapy [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4105 - 4112
- [6] Risk-Adapted Postmastectomy Radiotherapy Decision Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study [J]. FRONTIERS IN ONCOLOGY, 2020, 10
- [8] Risk-Adapted Postmastectomy Radiotherapy Strategies Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E14 - E15
- [9] Postmastectomy radiation therapy and survival outcome in older patients with T1-2N1 breast cancer [J]. BREAST, 2021, 59 : 308 - 313
- [10] Local-regional recurrence with and without radiation after neoadjuvant chemotherapy and mastectomy for T1-2/N0-1 breast cancer patients [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S88 - S89